Evidence map›Paper›PMID 30814582›Full record

ArticleScientific reports2019

Novel Chitohexaose Analog Protects Young and Aged mice from CLP Induced Polymicrobial Sepsis.

Pragnya Das, Santosh K Panda, Beamon Agarwal, Sumita Behera, Syed M Ali, Mark E Pulse, Joseph S Solomkin, Steven M Opal, Vineet Bhandari, Suchismita Acharya

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed, 1 pooled it
1.6field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 1 synthesis or guideline pooled it, 29 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Article
  5. Review
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Aged IRF3-KO Mice are Protected from Sepsis.Journal of inflammation research · 2021
    Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 7 institutions in 2 countries.

Pragnya DasDepartment of Pediatrics, Division of Neonatology, Drexel University School of Medicine, Philadelphia, PA, 19102, USA.
Santosh K PandaSchool of Medicine, Washington University, St. Louis, MO, 63110, USA.
Beamon AgarwalGenomeRxUS, 1250 Providence Rd, Secane, PA, 19018, USA.
Sumita BeheraAyuVis Research Inc, 1120 South Freeway, Fort Worth, TX, 76104, USA.
Syed M AliDepartment of Biotechnology, Jamia Millia Islamia, New Delhi, 110025, India.ORCID 0000-0003-2697-7832
Mark E PulsePreclinical Service, University of North Texas Health Science Center, Fort Worth, Texas, 76107, USA.
Joseph S SolomkinUniversity of Cincinnati College of Medicine, Cincinnati, OH, 45267, USA.
Steven M OpalThe Warren Alpert Medical School, Brown University, Providence, RI, 02903, USA.
Vineet BhandariDepartment of Pediatrics, Division of Neonatology, Drexel University School of Medicine, Philadelphia, PA, 19102, USA.ORCID 0000-0002-4900-6636
Suchismita AcharyaAyuVis Research Inc, 1120 South Freeway, Fort Worth, TX, 76104, USA. sacharya@ayuvis.com.
Drexel University · USUniversity of Cincinnati Medical Center · USUniversity of North Texas · USBrown University · USDepartment of Biotechnology · INProvidence College · USWashington University in St. Louis · US

Funding

U.S. Department of Health & Human Services | National Institutes of Health (NIH) R43AI129164-01
6 · The paper itself

Abstract

In Gram-negative bacterial sepsis, production of excess pro-inflammatory cytokines results in hyperinflammation and tissue injury. Anti-inflammatory cytokines such as IL-10 inhibit inflammation and enhance tissue healing. Here, we report a novel approach to treat septicemia associated with intra-abdominal infection in a murine model by delicately balancing pro- and anti-inflammatory cytokines. A novel oligosaccharide compound AVR-25 selectively binds to the TLR4 protein (IC

Indexed as

AgingAnimalsAnti-Inflammatory Agents, Non-SteroidalCecumCells, CulturedChitinCytokinesDisease Models, AnimalGram-Negative Bacterial InfectionsHumansInflammation MediatorsIntraabdominal InfectionsLeukocytes, MononuclearMiceMice, Inbred C57BLOligosaccharidesAnti-Inflammatory Agents, Non-SteroidalAVR-25ChitinchitohexaoseCytokinesInflammation MediatorsOligosaccharidesToll-Like Receptor 4

Identifiers

PMID30814582
PMCPMC6393422
OpenAlexW2918264357

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.